USA - NASDAQ:MDXG - US6024961012 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to MDXG. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-31 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-07-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-27 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-01 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-07-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-05-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-07 | Lake Street | Initiate | Buy |
| 2024-03-01 | Mizuho | Maintains | Buy -> Buy |
| 2023-10-31 | Mizuho | Maintains | Buy -> Buy |
| 2023-10-27 | Craig-Hallum | Initiate | Buy |
| 2023-08-02 | Mizuho | Maintains | Buy -> Buy |
| 2023-08-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-03 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-13 | Mizuho | Initiate | Buy |
| 2022-09-07 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-14 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-26 | Northland Capital Markets | Initiate | Outperform |
| 2021-03-19 | HC Wainwright & Co. | Initiate | Buy |
11 analysts have analysed MDXG and the average price target is 12.44 USD. This implies a price increase of 84.9% is expected in the next year compared to the current price of 6.73.
The consensus rating for MIMEDX GROUP INC (MDXG) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.